Key result
ChatGPT shows promise for HF care but data limitations and biases hinder widespread clinical adoption.
Why the study?
Heart failure causes substantial worldwide burden, and while emerging artificial intelligence technologies like ChatGPT offer opportunities to enhance care, their potential, limitations, and ethical issues require comprehensive evaluation.
While ChatGPT offers promising applications for heart failure management and patient education, significant limitations regarding data, bias, and ethics must be addressed before widespread clinical adoption.
Clinical adoption of ChatGPT in heart failure warrants caution until biases and ethics are resolved; leaves open targeted validation trials.
Heart failure (HF) is a leading cause of mortality, morbidity, and financial burden worldwide. The emergence of advanced artificial intelligence (AI) technologies, particularly Generative Pre-trained Transformer (GPT) systems, presents new opportunities to enhance HF management. In this review, we identified and examined existing studies on the use of ChatGPT in HF care by searching multiple medical databases (PubMed, Google Scholar, Medline, and Scopus). We assessed the role of ChatGPT in HF prevention, diagnosis, and management, focusing on its influence on clinical decision-making and patient education. However, ChatGPT faces limited training data, inherent biases, and ethical issues that hinder its widespread clinical adoption. We review these limitations and highlight the need for improved training approaches, greater model transparency, and robust regulatory compliance. Additionally, we explore the effectiveness of ChatGPT in managing HF, particularly in reducing hospital readmissions and improving patient outcomes with customized treatment plans while addressing social determinants of health (SDoH). In this review, we aim to provide healthcare professionals and policymakers with an in-depth understanding of ChatGPT's potential and constraints within the realm of HF care.
No takes yet. Share an insight, caveat, or question.
Ghanta et al. (2024) conducted a review in Heart failure. ChatGPT was evaluated. ChatGPT presents opportunities to enhance heart failure care, though widespread clinical adoption is hindered by limited training data, inherent biases, and ethical issues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: